Grant: Master's Award: Canada Graduate Scholarships
Université de Sherbrooke
$17,500.00
Elucidating the New DNA Repair Role for the Transcription Factor Hepatocyte Nuclear Factor 4a (HNF4a) in Colorectal Cancer
FY 2016-17
Summary
In Canada, colorectal cancer is one of the deadliest forms of cancer per the Canadian Cancer Society. Outcomes for patients affected by colorectal cancer are determined largely by the number of available treatments, and the number of treatments, in turn, depends on how well scientists and doctors are able to understand what causes the disease. Typically, cancer is a result of cells dividing too quickly because of a loss of control in their growth process. An important part of cell growth is the perfect copying of the cell's DNA, without error. These errors, or mutations, are frequently the causative factor of cancer. For colorectal cancer specifically, I have already determined through earlier experiments that the protein I propose to study, called HNF4 seems to be involved in the process of DNA repair. The goal of my master's project will be to determine how HNF4 is involved in DNA repair and to clarify the effect the molecule has in the development of colorectal cancer. Through experiments proposed in this application, we will be able to accurately determine the role that HNF4 has on DNA repair in cells and tissues affected by colorectal cancer. These experiments will help doctors and scientists better understand the disease to create more new treatments. Moreover, it could soon be possible to target HNF4 for therapeutic remedy in colorectal cancer thanks to the array of chemotherapeutic compounds directed already at defects in DNA damage repair.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367407
Name
Wilson Samuel D
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the New DNA Repair Role for the Transcription Factor Hepatocyte Nuclear Factor 4a (HNF4a) in Colorectal Cancer
Programtype2
Studentship Programs
Orgnameinp2
Université de Sherbrooke
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chemotherapeutics; Chromatin Interaction; Colorectal Cancer; Dna Damage; Dna Repair Mechanism; Organoid; Protein-Protein Interaction; Proteomics; Transcription Factor; Transcriptomics
Abstract
In Canada, colorectal cancer is one of the deadliest forms of cancer per the Canadian Cancer Society. Outcomes for patients affected by colorectal cancer are determined largely by the number of available treatments, and the number of treatments, in turn, depends on how well scientists and doctors are able to understand what causes the disease. Typically, cancer is a result of cells dividing too quickly because of a loss of control in their growth process. An important part of cell growth is the perfect copying of the cell's DNA, without error. These errors, or mutations, are frequently the causative factor of cancer. For colorectal cancer specifically, I have already determined through earlier experiments that the protein I propose to study, called HNF4 seems to be involved in the process of DNA repair. The goal of my master's project will be to determine how HNF4 is involved in DNA repair and to clarify the effect the molecule has in the development of colorectal cancer. Through experiments proposed in this application, we will be able to accurately determine the role that HNF4 has on DNA repair in cells and tissues affected by colorectal cancer. These experiments will help doctors and scientists better understand the disease to create more new treatments. Moreover, it could soon be possible to target HNF4 for therapeutic remedy in colorectal cancer thanks to the array of chemotherapeutic compounds directed already at defects in DNA damage repair.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wilson, Samuel D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~